|
US37650A
(en)
|
|
1863-02-10 |
|
Improvement in apparatus for obtaining profiles of submarine beds |
|
US36256A
(en)
|
|
1862-08-19 |
|
Improvement in sewing-m ach ines |
|
US47929A
(en)
|
|
1865-05-30 |
|
Improved grapnel for wells |
|
EP0124081A3
(en)
|
1983-05-02 |
1986-11-26 |
Merck & Co. Inc. |
New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them
|
|
US5132301A
(en)
|
1983-05-02 |
1992-07-21 |
Merck & Co., Inc. |
Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
|
|
USRE37650E1
(en)
|
1991-05-10 |
2002-04-09 |
Aventis Pharmacetical Products, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
DE69222637T2
(de)
|
1991-05-10 |
1998-02-26 |
Rhone Poulenc Rorer Int |
Bis mono- und bicyclische aryl- und heteroarylderivate mit inhibierender wirkung auf die egf und/oder pdgf-rezeptor tyrosinkinase
|
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
|
US6645969B1
(en)
|
1991-05-10 |
2003-11-11 |
Aventis Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
EP0541042A1
(de)
|
1991-11-05 |
1993-05-12 |
Hoechst Aktiengesellschaft |
Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
|
|
US5656643A
(en)
|
1993-11-08 |
1997-08-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
DE69819903T2
(de)
|
1997-08-09 |
2004-11-11 |
Smithkline Beecham P.L.C., Brentford |
Bicyclische verbindungen als liganden der 5-ht1 rezeptoren
|
|
DE10134721A1
(de)
|
2001-07-17 |
2003-02-06 |
Bayer Ag |
Tetrahydrochinoxaline
|
|
JP2005509028A
(ja)
|
2001-10-09 |
2005-04-07 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アスパラギン酸およびグルタミン酸誘導体ならびにそのジアゾケトン中間体を合成するための方法
|
|
KR100577179B1
(ko)
|
2001-10-30 |
2006-05-10 |
엘지전자 주식회사 |
유기 전계 발광 소자
|
|
US7078409B2
(en)
|
2002-03-28 |
2006-07-18 |
Beta Pharma, Inc. |
Fused quinazoline derivatives useful as tyrosine kinase inhibitors
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
CA2755297A1
(en)
|
2003-02-10 |
2004-08-26 |
Vertex Pharmaceuticals Incorporated |
Processes for the preparation of n-heteroaryl-n-aryl-amines by reacting an n-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
|
|
CN100579965C
(zh)
|
2003-02-10 |
2010-01-13 |
沃泰克斯药物股份有限公司 |
通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法
|
|
DE102004009238A1
(de)
|
2004-02-26 |
2005-09-08 |
Merck Patent Gmbh |
Arylamid-Derivate
|
|
ATE524182T1
(de)
|
2005-04-21 |
2011-09-15 |
Merck Serono Sa |
2,3-substituierte pyrazinsulfonamide als crth2- hemmer
|
|
KR20080058436A
(ko)
|
2005-10-13 |
2008-06-25 |
와이어쓰 |
글루탐산 유도체의 제조 방법
|
|
ATE541844T1
(de)
|
2005-12-21 |
2012-02-15 |
Abbott Lab |
Antivirale verbindungen
|
|
US8450348B2
(en)
|
2007-02-21 |
2013-05-28 |
Forma Tm, Llc |
Derivatives of squaric acid with anti-proliferative activity
|
|
JP5546450B2
(ja)
|
2007-05-21 |
2014-07-09 |
オスラム オプト セミコンダクターズ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
燐光発光金属錯体化合物、燐光発光金属錯体化合物を含有する発光素子、及び、燐光発光金属錯体化合物の製造法
|
|
TWI418608B
(zh)
|
2007-09-28 |
2013-12-11 |
Osram Opto Semiconductors Gmbh |
有機輻射發射元件
|
|
WO2009069132A2
(en)
|
2007-11-29 |
2009-06-04 |
Ramot At Tel Aviv University Ltd. |
Novel reverse transcriptase inhibitors
|
|
EP2231143B1
(en)
|
2007-12-13 |
2013-07-03 |
Merck Sharp & Dohme Corp. |
5H-pyrido[4,3-b]indoles as INHIBITORS OF JANUS KINASES
|
|
KR20100132550A
(ko)
*
|
2008-04-16 |
2010-12-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
US20130225528A1
(en)
|
2008-05-21 |
2013-08-29 |
Ariad Pharmaceuticals, Inc. |
Phosphorus Derivatives as Kinase Inhibitors
|
|
US20130225527A1
(en)
|
2008-05-21 |
2013-08-29 |
Ariad Pharmaceuticals, Inc. |
Phosphorus Derivatives as Kinase Inhibitors
|
|
JP2011523646A
(ja)
|
2008-05-21 |
2011-08-18 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
キナーゼ阻害剤としてのリン誘導体
|
|
GB0813403D0
(en)
|
2008-07-22 |
2008-08-27 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators & uses thereof
|
|
EP2149551A1
(de)
|
2008-07-30 |
2010-02-03 |
Bayer Schering Pharma AG |
N-(Indol-3-ylalkyl)-(hetero)arylamidderivate als Modulatoren des EP2-Rezeptors
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
DE102008061214A1
(de)
|
2008-12-09 |
2010-06-10 |
Merck Patent Gmbh |
Chinazolinamidderivate
|
|
EP2206712A1
(en)
|
2008-12-23 |
2010-07-14 |
CHIESI FARMACEUTICI S.p.A. |
"Alkaloid aminoester derivatives and medicinal composition thereof"
|
|
WO2010100144A1
(en)
|
2009-03-04 |
2010-09-10 |
Merck Serono S.A. |
Fused bicyclic compounds as inhibitors for pi3 kinase
|
|
WO2011026579A1
(en)
|
2009-09-04 |
2011-03-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
|
|
WO2011056957A2
(en)
|
2009-11-06 |
2011-05-12 |
Chelsea Therapeutics, Inc. |
Enzyme inhibiting compounds
|
|
WO2011113060A2
(en)
|
2010-03-12 |
2011-09-15 |
Trana Discovery, Inc. |
Antiviral compounds and methods of use thereof
|
|
JP2013538821A
(ja)
|
2010-09-24 |
2013-10-17 |
ランバクシー ラボラトリーズ リミテッド |
マトリックスメタロプロテイナーゼ阻害剤
|
|
WO2012079032A2
(en)
|
2010-12-09 |
2012-06-14 |
Trana Discovery, Inc. |
Compositions and methods of treating drug-resistant retroviral infections
|
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
|
WO2012172043A1
(en)
|
2011-06-15 |
2012-12-20 |
Laboratoire Biodim |
Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections
|
|
NO3175985T3
(cg-RX-API-DMAC7.html)
|
2011-07-01 |
2018-04-28 |
|
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
WO2013004984A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Tricyclic compounds for use as kinase inhibitors
|
|
WO2013005041A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Tricyclic heterocyclic compounds as kinase inhibitors
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2874987A1
(en)
|
2012-06-01 |
2013-12-05 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
US9853756B2
(en)
|
2012-11-07 |
2017-12-26 |
Qualcomm Incorporated |
Multicast over wireless network with the assistance of power-efficient peer group discovery
|
|
HRP20220766T1
(hr)
|
2012-11-08 |
2022-09-16 |
Bristol-Myers Squibb Company |
Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora
|
|
EP2922841B8
(en)
|
2012-11-08 |
2017-08-02 |
Bristol-Myers Squibb Company |
Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
CA2890935A1
(en)
|
2012-11-08 |
2014-05-15 |
Bristol-Myers Squibb Company |
Alkyl amide-substituted pyrimidine compounds useful in the modulation of il-12, il-23 and/or ifn.alpha.
|
|
WO2014120683A1
(en)
|
2013-01-29 |
2014-08-07 |
Children's Hospital Medical Center |
Small-molecule inhibitors targeting g-protein-coupled rho guanine nucleotide exchange factors
|
|
CN105188371A
(zh)
|
2013-02-08 |
2015-12-23 |
西建阿维拉米斯研究公司 |
Erk抑制剂及其用途
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
WO2015013715A2
(en)
|
2013-07-26 |
2015-01-29 |
Thr Regents Of The University Of California |
C-h fluorination of heterocycles with silver (ii) fluoride
|
|
EP2873663A1
(en)
*
|
2013-11-19 |
2015-05-20 |
Université de Strasbourg |
Novel uncharged reactivators against OP-inhibition of human acetylcholinesterase
|
|
WO2015129927A1
(en)
|
2014-02-26 |
2015-09-03 |
Kyorin Pharmaceutical Co., Ltd. |
Heterocyclic compounds
|
|
GB201405359D0
(en)
|
2014-03-25 |
2014-05-07 |
Univ Liverpool |
Synthetic process
|
|
GB2533925A
(en)
|
2014-12-31 |
2016-07-13 |
Univ Bath |
Antimicrobial compounds, compositions and methods
|
|
WO2016138352A1
(en)
|
2015-02-27 |
2016-09-01 |
Nimbus Lakshmi, Inc. |
Tyk2 inhibitors and uses thereof
|
|
WO2016149756A1
(en)
|
2015-03-23 |
2016-09-29 |
The University Of Melbourne |
Treatment of respiratory diseases
|
|
EP3290418B1
(en)
|
2015-04-29 |
2019-05-15 |
Wuxi Fortune Pharmaceutical Co., Ltd |
Janus kinase (jak) inhibitors
|
|
TW201705961A
(zh)
|
2015-06-11 |
2017-02-16 |
阿爾米雷爾有限公司 |
作為jak抑制劑的2-(吡唑并吡啶-3-基)嘧啶衍生物
|
|
WO2016207345A1
(en)
|
2015-06-24 |
2016-12-29 |
Pierre Fabre Medicament |
3-amino-pyrazin-2-yl carboxamide and 2-amino-pyridin-3-yl carboxamide derivatives as polo-like kinase 1 (plk-1) inhibitors for the treatment of cancer
|
|
WO2017005832A1
(en)
|
2015-07-09 |
2017-01-12 |
Solvay Specialty Polymers Italy S.P.A. |
Process for the synthesis of (per)fluoropolyether amines
|
|
KR101726059B1
(ko)
|
2015-07-28 |
2017-04-12 |
한양대학교 산학협력단 |
디피롤 유도체와 암모늄 염을 포함하는 브롬화수소 가스 검출용 조성물 및 이를 포함하는 브롬화수소 가스 검출용 색변환 센서
|
|
KR101766961B1
(ko)
|
2015-07-28 |
2017-08-09 |
한양대학교 산학협력단 |
트리페닐이미다졸 유도체와 암모늄 염을 포함하는 메틸아민 가스 검출용 조성물 및 이를 포함하는 메틸아민 가스 검출용 색변환 센서
|
|
GB201513481D0
(en)
|
2015-07-30 |
2015-09-16 |
Univ Manchester |
Inhibitor compounds
|
|
MX2018008169A
(es)
|
2015-12-30 |
2019-02-20 |
Agios Pharmaceuticals Inc |
Tratamiento de tumores que incorpora isocitrato deshidrogenasa mutante.
|
|
WO2017161028A1
(en)
|
2016-03-16 |
2017-09-21 |
Kura Oncology, Inc. |
Substituted inhibitors of menin-mll and methods of use
|
|
BR112018070494A2
(pt)
|
2016-04-06 |
2019-01-29 |
Koninklijke Philips Nv |
carimbo para um processo de litografia por impressão, método de fabricação de um carimbo, kit de peças para a fabricação de um carimbo, método de formação de uma camada dotada de um padrão e uso de um carimbo
|
|
CN105820175B
(zh)
|
2016-04-13 |
2019-09-20 |
四川大学 |
一种噻吩并嘧啶类化合物及其制备方法和应用
|
|
IL307931A
(en)
|
2016-04-15 |
2023-12-01 |
Epizyme Inc |
Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
|
|
CA3158951A1
(en)
|
2016-08-15 |
2018-02-22 |
Purdue Research Foundation |
4-substituted aminoisoquinoline derivatives
|
|
CN107880038B
(zh)
|
2016-09-30 |
2021-09-28 |
中国医药研究开发中心有限公司 |
[1,2,4]三唑并[1,5-a]吡啶类化合物及其制备方法和医药用途
|
|
TWI763722B
(zh)
|
2016-10-14 |
2022-05-11 |
美商林伯士拉克許米公司 |
Tyk2抑制劑及其用途
|
|
WO2018151830A1
(en)
*
|
2017-02-17 |
2018-08-23 |
Fronthera U.S. Pharmaceuticals Llc |
Pyridinyl based apoptosis signal-regulation kinase inhibitors
|
|
GB201704327D0
(en)
|
2017-03-17 |
2017-05-03 |
Argonaut Therapeutics Ltd |
Compounds
|
|
AU2018243749A1
(en)
|
2017-03-31 |
2019-11-21 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors
|
|
WO2018195450A1
(en)
|
2017-04-21 |
2018-10-25 |
Epizyme, Inc. |
Combination therapies with ehmt2 inhibitors
|
|
CN109020957B
(zh)
|
2017-06-12 |
2023-01-13 |
南京天印健华医药科技有限公司 |
作为mnk抑制剂的杂环化合物
|
|
EP3694861A4
(en)
|
2017-10-09 |
2021-05-19 |
Nuvation Bio Inc. |
HETEROCYCLIC COMPOUNDS AND USES THEREOF
|
|
US20210213014A1
(en)
|
2017-10-18 |
2021-07-15 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors in immunotherapies
|
|
AU2018353150B2
(en)
|
2017-10-18 |
2024-06-06 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors in treating or preventing blood disorders
|
|
GB201717260D0
(en)
|
2017-10-20 |
2017-12-06 |
Galapagos Nv |
Novel compounds and pharma ceutical compositions thereof for the treatment of inflammatory disorders
|
|
MY202167A
(en)
|
2017-11-21 |
2024-04-12 |
Bristol Myers Squibb Co |
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
|
|
BR112020009757A2
(pt)
|
2017-12-15 |
2020-11-03 |
Revolution Medicines, Inc. |
compostos policíclicos como inibidores alostéricos de shp2
|
|
US11479555B2
(en)
|
2018-02-23 |
2022-10-25 |
Newave Pharmaceutical Inc. |
Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones as inhibitors of WEE-1 kinase
|
|
WO2019209182A1
(en)
|
2018-04-25 |
2019-10-31 |
Nanyang Technological University |
Conjugated oligoelectrolytes as antimicrobial agents
|
|
WO2019226991A1
(en)
|
2018-05-25 |
2019-11-28 |
Essa Pharma, Inc. |
Androgen receptor modulators and methods for their use
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
JP2021536458A
(ja)
|
2018-09-04 |
2021-12-27 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
アリール炭化水素レセプター・アンタゴニスト及び使用方法
|
|
JP2022508651A
(ja)
|
2018-10-08 |
2022-01-19 |
レヴォリューション・メディスンズ,インコーポレイテッド |
癌を処置するためのshp2阻害剤組成物および方法
|
|
RS66346B1
(sr)
|
2018-10-22 |
2025-01-31 |
Alumis Inc |
Inhibitori tyk2 i njihova upotreba
|
|
US12098117B2
(en)
|
2018-12-11 |
2024-09-24 |
Duke University |
Compositions and methods for the treatment of cancer
|
|
EP3673920A1
(en)
|
2018-12-28 |
2020-07-01 |
Universität Wien |
Polyphenol-peptide conjugates for nuclear-targeted delivery
|
|
KR102943760B1
(ko)
|
2019-01-28 |
2026-03-26 |
장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 |
피리다진 유도체 억제제, 및 그의 제조 방법 및 용도
|
|
CN111484480B
(zh)
|
2019-01-29 |
2023-08-11 |
上海翰森生物医药科技有限公司 |
一种多环类衍生物抑制剂、其制备方法和应用
|
|
GB201903085D0
(en)
|
2019-03-07 |
2019-04-24 |
Univ Oxford Innovation Ltd |
Passivation method
|
|
US20220177459A1
(en)
|
2019-04-02 |
2022-06-09 |
Hinova Pharmaceuticals Inc. |
Aromatic amine compound and use thereof in preparation of ar and brd4 dual inhibitors and regulators
|
|
WO2020222773A1
(en)
|
2019-04-30 |
2020-11-05 |
Celgene Corporation |
Combination therapies comprising apremilast and tyk2 inhibitors
|
|
CN112079830B
(zh)
|
2019-06-14 |
2023-12-22 |
上海翰森生物医药科技有限公司 |
含并环类衍生物抑制剂、其制备方法和应用
|
|
KR102877616B1
(ko)
|
2019-07-01 |
2025-10-28 |
삼성디스플레이 주식회사 |
조성물 및 이를 포함한 유기 발광 소자
|
|
WO2021001739A1
(en)
|
2019-07-02 |
2021-01-07 |
Effector Therapeutics, Inc. |
Translational enhancers and related methods
|
|
WO2021014453A1
(en)
|
2019-07-24 |
2021-01-28 |
Sol-Gel Technologies Ltd. |
Topical jak inhibitor combination compositions for treatment of inflammatory skin conditions
|
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
|
IL291452B1
(en)
|
2019-09-18 |
2026-06-01 |
Bristol Myers Squibb Co |
Dosage forms for TYK2 inhibitors
|
|
CN112851579A
(zh)
|
2019-11-27 |
2021-05-28 |
衡阳师范学院 |
用于铜催化卤代芳烃偶联反应的配体化合物、催化体系和偶联反应
|
|
WO2021133917A1
(en)
|
2019-12-23 |
2021-07-01 |
Kymera Therapeutics, Inc. |
Smarca inhibitors and uses thereof
|
|
US20230128972A1
(en)
|
2020-01-31 |
2023-04-27 |
Atomwise Inc. |
Anat Inhibitors and Methods of Use Thereof
|
|
ES2981764T3
(es)
|
2020-03-11 |
2024-10-10 |
Beijing Innocare Pharma Tech Co Ltd |
Compuestos heterocíclicos para inhibir las actividades de TYK2
|
|
KR20230004771A
(ko)
|
2020-04-28 |
2023-01-06 |
브리스톨-마이어스 스큅 컴퍼니 |
Il-12, il-23 및/또는 ifn알파 조정제로서의 치환된 n-(메틸-d3)피리다진-3-카르복스아미드 또는 n-(메틸-d3)-니코틴아미드 화합물
|
|
IL298966A
(en)
|
2020-06-11 |
2023-02-01 |
Betta Pharmaceuticals Co Ltd |
Bicyclic compound and application thereof
|
|
CN115667246B
(zh)
|
2020-07-24 |
2024-08-23 |
上海翰森生物医药科技有限公司 |
一种哒嗪类衍生物自由碱的晶型及其制备方法和应用
|
|
CN113968846A
(zh)
|
2020-07-24 |
2022-01-25 |
上海翰森生物医药科技有限公司 |
一种哒嗪类衍生物的盐、晶型及其制备方法和应用
|
|
US20220144842A1
(en)
|
2020-11-04 |
2022-05-12 |
Eternity Bioscience Inc. |
Irak inhibitors, preparation method and medicinal uses thereof
|
|
US20230416225A1
(en)
|
2020-11-09 |
2023-12-28 |
Merck Sharp & Dohme Llc |
Diaminopyrimidine carboxamide inhibitors of hpk1
|
|
US12668594B2
(en)
|
2020-12-23 |
2026-06-30 |
Sudo Biosciences Limited |
TYK2 inhibitors and uses thereof
|
|
KR20230159421A
(ko)
|
2021-02-19 |
2023-11-21 |
수도 바이오사이언시즈 리미티드 |
Tyk2 억제제 및 이의 용도
|
|
IL305119A
(en)
|
2021-02-19 |
2023-10-01 |
Sudo Biosciences Ltd |
Tyk2 inhibitors and uses thereof
|
|
TW202302583A
(zh)
|
2021-02-19 |
2023-01-16 |
英商蘇多生物科學有限公司 |
Tyk2抑制劑及其用途
|
|
WO2022175745A1
(en)
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
JP2022143679A
(ja)
|
2021-03-18 |
2022-10-03 |
株式会社リコー |
光電変換素子、電子機器、及び電源モジュール
|
|
US12054506B2
(en)
|
2021-03-19 |
2024-08-06 |
Singular Genomics Systems, Inc. |
Reducing agents and uses thereof
|
|
WO2022226349A1
(en)
|
2021-04-22 |
2022-10-27 |
Essa Pharma, Inc. |
Androgen receptor modulators and methods for their use
|
|
US12560054B2
(en)
|
2021-04-30 |
2026-02-24 |
Board Of Regents, The University Of Texas System |
Use of carboxylates for carbon sequestration, improved oil recovery, and hydrogen storage and reproduction
|
|
KR20240008338A
(ko)
|
2021-05-14 |
2024-01-18 |
브리스톨-마이어스 스큅 컴퍼니 |
치환된 헤테로시클릭 화합물
|
|
US20240317718A1
(en)
|
2021-05-14 |
2024-09-26 |
Bristol-Myers Squibb Company |
Substituted heterocyclic compounds
|
|
KR20240007242A
(ko)
|
2021-05-14 |
2024-01-16 |
브리스톨-마이어스 스큅 컴퍼니 |
치환된 헤테로시클릭 화합물
|
|
PE20250262A1
(es)
|
2021-05-14 |
2025-01-29 |
Bristol Myers Squibb Co |
Compuestos heterociclicos sustituidos
|
|
EP4337650A1
(en)
|
2021-05-14 |
2024-03-20 |
Bristol-Myers Squibb Company |
Substituted heterocyclic compounds
|
|
WO2023227946A1
(en)
|
2022-05-27 |
2023-11-30 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US20260055121A1
(en)
|
2022-08-24 |
2026-02-26 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
WO2024246602A1
(en)
|
2023-05-26 |
2024-12-05 |
Sudo Biosciences Limited |
Fused azoled as tyk2 inhibitors and uses thereof
|
|
IL324864A
(en)
|
2023-05-26 |
2026-01-01 |
Sudo Biosciences Ltd |
Compressed azines as tyk2 inhibitors and their uses
|
|
WO2025114761A1
(en)
|
2023-11-29 |
2025-06-05 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
IL328235A
(en)
|
2023-11-29 |
2026-07-01 |
Sudo Biosciences Ltd |
TYK2 inhibitors and their uses
|